S-1 Filing

Oruka Therapeutics, Inc. CIK: 907654

Filing Information

Form Type	S-1
Accession Number	`0001213900-24-097737`
Period End Date	20240930
Filing Date	20241114
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	ea0220567-s1_orukatherap_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 104 Income Statement 52 Cash Flow Statement 74 Stockholders Equity 50

Balance Sheet 104 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$410.88M	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$410.88M	USD	Point-in-time
Subscription receivable	`SubscriptionReceivables`	-	USD	Point-in-time
Subscription receivable	`SubscriptionReceivables`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	65.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	65.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	545.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	545.00M	shares	Point-in-time
Subscription receivable	`SubscriptionReceivables`	$1.00K	USD	Point-in-time
Subscription receivable	`SubscriptionReceivables`	$1.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.07M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.07M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	35.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	35.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	-	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.20M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.20M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$412.95M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$412.95M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.20M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.20M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	35.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	35.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$160.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$160.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$938.00K	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$938.00K	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$43.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$43.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Total assets	`Assets`	$414.09M	USD	Point-in-time
Total assets	`Assets`	$414.09M	USD	Point-in-time
Total assets	`Assets`	$1.00K	USD	Point-in-time
Total assets	`Assets`	$1.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.15M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.15M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	-	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	-	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$1.71M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$1.71M	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$146.00K	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$146.00K	USD	Point-in-time
Related party accounts payable and other current liabilities	`OtherLiabilitiesCurrent`	-	USD	Point-in-time
Related party accounts payable and other current liabilities	`OtherLiabilitiesCurrent`	-	USD	Point-in-time
Related party accounts payable and other current liabilities	`OtherLiabilitiesCurrent`	$6.36M	USD	Point-in-time
Related party accounts payable and other current liabilities	`OtherLiabilitiesCurrent`	$6.36M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.04M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.04M	USD	Point-in-time
Operating lease liability, non-current	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Operating lease liability, non-current	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Operating lease liability, non-current	`OperatingLeaseLiabilityNoncurrent`	$842.00K	USD	Point-in-time
Operating lease liability, non-current	`OperatingLeaseLiabilityNoncurrent`	$842.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$18.88M	USD	Point-in-time
Total liabilities	`Liabilities`	$18.88M	USD	Point-in-time
Total liabilities	`Liabilities`	-	USD	Point-in-time
Total liabilities	`Liabilities`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, value	`CommonStockValue`	-	USD	Point-in-time
Common stock, value	`CommonStockValue`	-	USD	Point-in-time
Common stock, value	`CommonStockValue`	$35.00K	USD	Point-in-time
Common stock, value	`CommonStockValue`	$35.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$397.35M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$397.35M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-57.94M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-57.94M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-28.98M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-28.98M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-7.06M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-7.06M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$342.37M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$342.37M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders equity	`LiabilitiesAndStockholdersEquity`	$414.09M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders equity	`LiabilitiesAndStockholdersEquity`	$414.09M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.00K	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.00K	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$25.69M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$25.69M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$49.56M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$49.56M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.76M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.76M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.25M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.25M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$57.80M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$57.80M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$29.45M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$29.45M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-29.45M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-29.45M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-57.80M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-57.80M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.33M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.33M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.33M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.33M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$504.00K	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$504.00K	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$1.47M	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$1.47M	USD	3 Qtrs
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$-138.00K	USD	3 Qtrs
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$-138.00K	USD	3 Qtrs
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$826.00K	USD	1 Quarter
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$826.00K	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-28.62M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-28.62M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-7.08M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-7.08M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-57.94M	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-57.94M	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-22.24M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-22.24M	USD	1 Quarter
Net loss per share attributable, basic (in Dollars per share)	`EarningsPerShareBasic`	$-6.08	USD	3 Qtrs
Net loss per share attributable, basic (in Dollars per share)	`EarningsPerShareBasic`	$-6.08	USD	3 Qtrs
Net loss per share attributable, basic (in Dollars per share)	`EarningsPerShareBasic`	$-1.46	USD	1 Quarter
Net loss per share attributable, basic (in Dollars per share)	`EarningsPerShareBasic`	$-1.46	USD	1 Quarter
Net loss per share attributable, diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-1.46	USD	1 Quarter
Net loss per share attributable, diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-1.46	USD	1 Quarter
Net loss per share attributable, diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-6.08	USD	3 Qtrs
Net loss per share attributable, diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-6.08	USD	3 Qtrs
Weighted-average shares used in computing net loss per share attributable, basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.77M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share attributable, basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.77M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share attributable, basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	15.01M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable, basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	15.01M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable, diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.77M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share attributable, diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.77M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share attributable, diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	15.01M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable, diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	15.01M	shares	1 Quarter

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-28.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-28.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-57.94M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-57.94M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-22.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.24M	USD	1 Quarter
Depreciation expense	`Depreciation`	$11.00K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$11.00K	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$9.77M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$9.77M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$9.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$9.00M	USD	1 Quarter
Non-cash interest expense	`OtherNoncashExpense`	$1.47M	USD	3 Qtrs
Non-cash interest expense	`OtherNoncashExpense`	$1.47M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseExpense`	$65.00K	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseExpense`	$65.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$1.98M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$1.98M	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$43.00K	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$43.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$1.62M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$1.62M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.65M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.65M	USD	3 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$6.00K	USD	3 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$6.00K	USD	3 Qtrs
Related party accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableRelatedParties`	$6.36M	USD	3 Qtrs
Related party accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableRelatedParties`	$6.36M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-39.02M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-39.02M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$171.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$171.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-171.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-171.00K	USD	3 Qtrs
Proceeds from issuance of Pre-Merger Oruka Series A Preferred Stock, net of issuance costs paid	`ProceedsFromIssuanceOfPreMergerOrukaSeriesAPreferredStockNetOfIssuanceCostsPaid`	$2.93M	USD	3 Qtrs
Proceeds from issuance of Pre-Merger Oruka Series A Preferred Stock, net of issuance costs paid	`ProceedsFromIssuanceOfPreMergerOrukaSeriesAPreferredStockNetOfIssuanceCostsPaid`	$2.93M	USD	3 Qtrs
Proceeds from issuance of notes payable to related parties, net of issuance costs paid	`ProceedsFromNotesPayable`	$24.98M	USD	3 Qtrs
Proceeds from issuance of notes payable to related parties, net of issuance costs paid	`ProceedsFromNotesPayable`	$24.98M	USD	3 Qtrs
Proceeds from the Pre-Closing Financing, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$228.13M	USD	3 Qtrs
Proceeds from the Pre-Closing Financing, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$228.13M	USD	3 Qtrs
Proceeds from the PIPE Financing, net	`ProceedsFromIssuanceOfPrivatePlacement`	$189.09M	USD	3 Qtrs
Proceeds from the PIPE Financing, net	`ProceedsFromIssuanceOfPrivatePlacement`	$189.09M	USD	3 Qtrs
Cash acquired in connection with the reverse recapitalization	`CashAssumedInConnectionWithTheReverseRecapitalization`	$4.94M	USD	3 Qtrs
Cash acquired in connection with the reverse recapitalization	`CashAssumedInConnectionWithTheReverseRecapitalization`	$4.94M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$450.06M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$450.06M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$410.88M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$410.88M	USD	3 Qtrs
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$410.88M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$410.88M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$410.88M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$410.88M	USD	Point-in-time
Operating lease liability arising from obtaining operating right-of-use asset	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$982.00K	USD	3 Qtrs
Operating lease liability arising from obtaining operating right-of-use asset	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$982.00K	USD	3 Qtrs
Assets acquired in connection with the reverse recapitalization	`NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1`	$114.00K	USD	3 Qtrs
Assets acquired in connection with the reverse recapitalization	`NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1`	$114.00K	USD	3 Qtrs
Other liabilities assumed in connection with the reverse recapitalization	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	$54.00K	USD	3 Qtrs
Other liabilities assumed in connection with the reverse recapitalization	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	$54.00K	USD	3 Qtrs
Pre-Closing Financing and reverse recapitalization issuance costs included in accounts payable	`UnpaidPreclosingFinancingAndReverseRecapitalizationIssuanceCostsIncludedInAccountsPayable`	$150.00K	USD	3 Qtrs
Pre-Closing Financing and reverse recapitalization issuance costs included in accounts payable	`UnpaidPreclosingFinancingAndReverseRecapitalizationIssuanceCostsIncludedInAccountsPayable`	$150.00K	USD	3 Qtrs
PIPE Financing issuance costs included in accounts payable	`UnpaidPIPEFinancingIssuanceCostsIncludedInAccountsPayable`	$374.00K	USD	3 Qtrs
PIPE Financing issuance costs included in accounts payable	`UnpaidPIPEFinancingIssuanceCostsIncludedInAccountsPayable`	$374.00K	USD	3 Qtrs
PIPE Financing issuance costs included in accrued expenses and other current liabilities	`UnpaidPIPEFinancingIssuanceCostsIncludedInAccruedExpensesAndOtherCurrentLiabilties`	$6.00K	USD	3 Qtrs
PIPE Financing issuance costs included in accrued expenses and other current liabilities	`UnpaidPIPEFinancingIssuanceCostsIncludedInAccruedExpensesAndOtherCurrentLiabilties`	$6.00K	USD	3 Qtrs
Non-cash accrued interest on convertible note converted to common stock	`NoncashAccruedInterestOnConvertibleNoteConvertedToCommonStock`	$1.47M	USD	3 Qtrs
Non-cash accrued interest on convertible note converted to common stock	`NoncashAccruedInterestOnConvertibleNoteConvertedToCommonStock`	$1.47M	USD	3 Qtrs
Non-cash exchange of Pre-Merger Oruka Series A Preferred Stock for Company Series B Convertible Preferred Stock	`DebtConversionConvertedInstrumentAmount1`	$2.93M	USD	3 Qtrs
Non-cash exchange of Pre-Merger Oruka Series A Preferred Stock for Company Series B Convertible Preferred Stock	`DebtConversionConvertedInstrumentAmount1`	$2.93M	USD	3 Qtrs

Stockholders Equity 50 line items

Line Item	Tag	Value	Unit	Period
Issuance of Series A convertible preferred stock, net of issuance costs	`IssuanceOfSeriesAConvertiblePreferredStockNetOfIssuanceCosts`	$69.00K	USD	1 Quarter
Issuance of Series A convertible preferred stock, net of issuance costs	`IssuanceOfSeriesAConvertiblePreferredStockNetOfIssuanceCosts`	$69.00K	USD	1 Quarter
Balances	`StockholdersEquity`	$-28.98M	USD	Point-in-time
Balances	`StockholdersEquity`	$-28.98M	USD	Point-in-time
Balances	`StockholdersEquity`	$1.00K	USD	Point-in-time
Balances	`StockholdersEquity`	$1.00K	USD	Point-in-time
Balances	`StockholdersEquity`	$-7.06M	USD	Point-in-time
Balances	`StockholdersEquity`	$-7.06M	USD	Point-in-time
Balances	`StockholdersEquity`	$342.37M	USD	Point-in-time
Balances	`StockholdersEquity`	$342.37M	USD	Point-in-time
Issuance of common stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of Series A convertible preferred stock, net of issuance costs of $69	`StockIssuedDuringPeriodValueOther`	-	USD	1 Quarter
Issuance of Series A convertible preferred stock, net of issuance costs of $69	`StockIssuedDuringPeriodValueOther`	-	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$321.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$321.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.75M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.75M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.00K	USD	1 Quarter
Exchange of Series A convertible preferred stock for Series B non-voting convertible preferred stock upon the closing of the reverse recapitalization	`ExchangeOfSeriesAConvertiblePreferredStockForSeriesBNonvotingConvertiblePreferredSt`	$2.93M	USD	1 Quarter
Exchange of Series A convertible preferred stock for Series B non-voting convertible preferred stock upon the closing of the reverse recapitalization	`ExchangeOfSeriesAConvertiblePreferredStockForSeriesBNonvotingConvertiblePreferredSt`	$2.93M	USD	1 Quarter
Conversion of convertible notes (including accrued interest) into common stock upon the closing of the reverse recapitalization	`StockIssuedDuringPeriodValueConversionOfUnits`	$26.45M	USD	1 Quarter
Conversion of convertible notes (including accrued interest) into common stock upon the closing of the reverse recapitalization	`StockIssuedDuringPeriodValueConversionOfUnits`	$26.45M	USD	1 Quarter
Issuance of common stock and pre-funded warrants in the Pre-Closing Financing,	`IssuanceOfCommonStockAndPrefundedWarrantsInThePreclosingFinancingNetOfOfferingCos`	$248.46M	USD	1 Quarter
Issuance of common stock and pre-funded warrants in the Pre-Closing Financing,	`IssuanceOfCommonStockAndPrefundedWarrantsInThePreclosingFinancingNetOfOfferingCos`	$248.46M	USD	1 Quarter
Issuance costs of Pre-Closing Financing and reverse recapitalization	`IssuanceCostsOfPreclosingFinancingAndReverseRecapitalization`	$-20.48M	USD	1 Quarter
Issuance costs of Pre-Closing Financing and reverse recapitalization	`IssuanceCostsOfPreclosingFinancingAndReverseRecapitalization`	$-20.48M	USD	1 Quarter
Issuance of common stock to former stockholders of ARCA biopharma, Inc. in connection with the closing of the reverse recapitalization	`AdjustmentForChangeInCommonStockParValueInConnectionWithTheReverseMerger`	$5.00M	USD	1 Quarter
Issuance of common stock to former stockholders of ARCA biopharma, Inc. in connection with the closing of the reverse recapitalization	`AdjustmentForChangeInCommonStockParValueInConnectionWithTheReverseMerger`	$5.00M	USD	1 Quarter
Issuance of common stock, Series A non-voting convertible preferred stock, and pre-funded warrants in connection with the PIPE Financing	`IssuanceOfCommonStockSeriesANonvotingConvertiblePreferredStockAndPrefundedWarr`	$144.44M	USD	1 Quarter
Issuance of common stock, Series A non-voting convertible preferred stock, and pre-funded warrants in connection with the PIPE Financing	`IssuanceOfCommonStockSeriesANonvotingConvertiblePreferredStockAndPrefundedWarr`	$144.44M	USD	1 Quarter
Issuance cost of PIPE Financing	`IssuanceCostOfPIPEFinancing`	$-8.57M	USD	1 Quarter
Issuance cost of PIPE Financing	`IssuanceCostOfPIPEFinancing`	$-8.57M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-28.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-28.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-57.94M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-57.94M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-22.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.24M	USD	1 Quarter
Balances	`StockholdersEquity`	$-28.98M	USD	Point-in-time
Balances	`StockholdersEquity`	$-28.98M	USD	Point-in-time
Balances	`StockholdersEquity`	$1.00K	USD	Point-in-time
Balances	`StockholdersEquity`	$1.00K	USD	Point-in-time
Balances	`StockholdersEquity`	$-7.06M	USD	Point-in-time
Balances	`StockholdersEquity`	$-7.06M	USD	Point-in-time
Balances	`StockholdersEquity`	$342.37M	USD	Point-in-time
Balances	`StockholdersEquity`	$342.37M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.